Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan van Meerbeeck

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 28, 2015
Money rules the worldPaul Baas, Jan van Meerbeeck
Translational Lung Cancer Research|November 20, 2018
Malignant pleural and peritoneal mesothelioma: clinical update 2018Paul Van Schil, Jan Van Meerbeeck
Annals of Palliative Medicine|April 6, 2015
End of life care in lung cancer patients: not at life's end?Annelies Janssens, Liesbeth Teugels, Jan van Meerbeeck
The Lancet. Oncology|September 3, 2013
Surgery or radiotherapy for early-stage lung cancer--a potential comparison biasPaul E Van Schil, Jan Van Meerbeeck
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 10, 2025
Radical Surgery in Pleural Mesothelioma: Houston, We Have a ProblemJo Raskin, Jan van Meerbeeck, Paul Van Schil
The European Respiratory Journal|October 29, 2021
Targeted adjuvant therapy in non-small cell lung cancer: trick or treat?Lizza E L Hendriks, Jan van Meerbeeck, Jacques Cadranel
Oncotarget|June 9, 2022
Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)?Birgitta Hiddinga, Karen Zwaenepoel, Annelies Janssens, et al.
Patient Education and Counseling|March 31, 2005
Willingness of pulmonologists to guide COPD patients in smoking cessationCatherine Bolman, Carolien Sino, Paul Hekking, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 2, 2008
The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th EditionJean-Paul Sculier, Kari Chansky, John J Crowley, et al.
Nature Clinical Practice. Oncology|January 30, 2008
Advances in the systemic therapy of malignant pleural mesotheliomaDean A Fennell, Giovanni Gaudino, Kenneth J O'Byrne, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Lung Cancer (Amsterdam, Netherlands)|November 28, 2015
Money rules the worldPaul Baas, Jan van Meerbeeck
Translational Lung Cancer Research|November 20, 2018
Malignant pleural and peritoneal mesothelioma: clinical update 2018Paul Van Schil, Jan Van Meerbeeck
Annals of Palliative Medicine|April 6, 2015
End of life care in lung cancer patients: not at life's end?Annelies Janssens, Liesbeth Teugels, Jan van Meerbeeck
The Lancet. Oncology|September 3, 2013
Surgery or radiotherapy for early-stage lung cancer--a potential comparison biasPaul E Van Schil, Jan Van Meerbeeck
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 10, 2025
Radical Surgery in Pleural Mesothelioma: Houston, We Have a ProblemJo Raskin, Jan van Meerbeeck, Paul Van Schil
The European Respiratory Journal|October 29, 2021
Targeted adjuvant therapy in non-small cell lung cancer: trick or treat?Lizza E L Hendriks, Jan van Meerbeeck, Jacques Cadranel
Oncotarget|June 9, 2022
Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)?Birgitta Hiddinga, Karen Zwaenepoel, Annelies Janssens, et al.
Patient Education and Counseling|March 31, 2005
Willingness of pulmonologists to guide COPD patients in smoking cessationCatherine Bolman, Carolien Sino, Paul Hekking, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 2, 2008
The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th EditionJean-Paul Sculier, Kari Chansky, John J Crowley, et al.
Nature Clinical Practice. Oncology|January 30, 2008
Advances in the systemic therapy of malignant pleural mesotheliomaDean A Fennell, Giovanni Gaudino, Kenneth J O'Byrne, et al.
Pageof 6